Clinical trial
A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors
NCT00455052
Study timeline
Study start (actual)2011-03-01Date precision: month
Registry last updated2018-01-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Small Cell Lung Cancerunresolved
Non-small Cell Lung Cancerunresolved
Interventions
XMT-1001DRUG
Sponsors & collaborators
Mersana Therapeuticslead sponsor
Mapped research locations
New YorkNew York, United States1BaltimoreMaryland, United States1IndianapolisIndiana, United States1DenverColorado, United States1Las VegasNevada, United States1ScottsdaleArizona, United States1SpokaneWashington, United States1GreenvilleSouth Carolina, United States1NorfolkVirginia, United States1TylerTexas, United States1VancouverWashington, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00455052 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.